GPC2 May Be an Immunotherapeutic Target in High-Risk Neuroblastoma [Research Watch]

A GPC2-targeting antibody–drug conjugate promotes tumor regression in a high-risk neuroblastoma PDX.

from Cancer via ola Kala on Inoreader http://ift.tt/2ywjuD0
via IFTTT